Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2015
16th World Conference on Lung Cancer
Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado
Presentation Date(s):- September 6 - 9, 2015
- Total Presentations: 2499
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
-
+
P1.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 87
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.01-075 - Phase III, Randomized, Double-Blind Trial of Bavituximab Plus Docetaxel in Previously Treated Stage IIIb/IV Non-Squamous NSCLC (SUNRISE)
09:30 - 09:30 | Author(s): D.R. Spigel
- Abstract
Loading... -
+
P1.01-076 - TIGER-1: A Phase 2/3 Study of First Line Rociletinib or Erlotinib in EGFR-Mutant NSCLC
09:30 - 09:30 | Author(s): R. Camidge
- Abstract
Loading...
-
+
ORAL 02 - PD1 Axis Immunotherapy 2
- Type: Oral Session
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 8
- Moderators:E.B. Garon
- Coordinates: 9/07/2015, 10:45 - 12:15, Four Seasons Ballroom F1+F2
-
+
ORAL02.01 - Phase 3, Randomized Trial (CheckMate 017) of Nivolumab (NIVO) vs Docetaxel in Advanced Squamous (SQ) Cell Non-Small Cell Lung Cancer (NSCLC)
10:45 - 10:56 | Author(s): K. Reckamp
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ORAL 10 - SCLC
- Type: Oral Session
- Track: Small Cell Lung Cancer
- Presentations: 9
- Moderators:C. Faivre-Finn
- Coordinates: 9/07/2015, 10:45 - 12:15, 605+607
-
+
ORAL10.01 - A DLL3-Targeted ADC, Rovalpituzumab Tesirine, Demonstrates Substantial Activity in a Phase I Study in Relapsed and Refractory SCLC
11:05 - 11:16 | Author(s): C.M. Rudin
- Abstract
Loading...
-
+
MINI 08 - Prognostic/Predictive Biomarkers
- Type: Mini Oral
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 15
- Moderators:T.E. Stinchcombe
- Coordinates: 9/07/2015, 16:45 - 18:15, Mile High Ballroom 4a-4f
-
+
MINI08.03 - Discussant for MINI08.01, MINI08.02 & MINI08.02b
17:00 - 17:10 | Author(s): D.R. Spigel
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 102
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.01-090 - A Phase 2, Single Arm Study of Lucitanib in Patients with Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF-Related Genetic Changes
09:30 - 09:30 | Author(s): D.R. Spigel
- Abstract
Loading... -
+
P2.01-095 - nab-Paclitaxel/Carboplatin Followed By nab-Paclitaxel for NSCLC PS 2 (ABOUND.PS2)
09:30 - 09:30 | Author(s): A. Gajra
- Abstract
Loading... -
+
P2.01-099 - nab-Paclitaxel as Maintenance Therapy in Patients with Squamous Cell NSCLC (ABOUND.sqm)
09:30 - 09:30 | Author(s): D.R. Spigel
- Abstract
Loading...
-
+
P2.07 - Poster Session/ Small Cell Lung Cancer
- Type: Poster
- Track: Small Cell Lung Cancer
- Presentations: 18
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.07-010 - Alisertib (MLN8237)+Paclitaxel versus Placebo+Paclitaxel for Relapsed SCLC
09:30 - 09:30 | Author(s): T.K. Owonikoko
- Abstract
Loading...
-
+
P3.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 91
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.01-038 - Comparing Next-Generation Sequencing (NGS) Platforms in Patients with Thoracic Tumors: Tumor Tissue vs. Circulating Cell-Free DNA from Blood
09:30 - 09:30 | Author(s): M.L. Johnson
- Abstract
Loading... -
+
P3.01-084 - Avelumab (MSB0010718C), an Anti-PD-L1 Antibody, Evaluated in a Phase Ib Trial as a First-Line Treatment for Patients with Metastatic NSCLC
09:30 - 09:30 | Author(s): C. Verschraegen
- Abstract
Loading...
-
+
ED 11 - Extending Personalized Treatment Beyond EGFR
- Type: Education Session
- Track: Community Practice
- Presentations: 5
- Moderators:R. Perez-Soler
- Coordinates: 9/09/2015, 14:15 - 15:45, 401-404
-
+
ED11.03 - 1st Line and Beyond for ALK, ROS-1, BRAF, RET, FGFR Positive Lung Cancer
15:00 - 15:20 | Author(s): D.R. Spigel
- Abstract
Loading...
-
+
MINI 27 - Biology and Other Issues in SCLC
- Type: Mini Oral
- Track: Small Cell Lung Cancer
- Presentations: 15
- Moderators:P.A. Bunn, Jr
- Coordinates: 9/09/2015, 16:45 - 18:15, 605+607
-
+
MINI27.08 - NOTCH3 Protein Expression and Outcome in Small Cell Lung Cancer (SCLC) and Therapeutic Targeting with Tarextumab (Anti-Notch 2/3)
17:25 - 17:30 | Author(s): A. Chiang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MINI 30 - New Kinase Targets
- Type: Mini Oral
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 15
- Moderators:K. Park
- Coordinates: 9/09/2015, 18:30 - 20:00, Four Seasons Ballroom F3+F4
-
+
MINI30.02 - Phase II Study of Defactinib, VS-6063, a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
18:35 - 18:40 | Author(s): D.E. Gerber
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MINI30.13 - A Phase II Trial of Pictilisib with Chemotherapy in First-Line Squamous NSCLC
19:40 - 19:45 | Author(s): D.R. Spigel
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.